Structures by: Weyna D.
Total: 16
C19H15N3O
C19H15N3O
Molecular Pharmaceutics (2007) 4, 3 401
a=18.715(8)Å b=7.228(3)Å c=23.208(9)Å
α=90.00° β=90.478(12)° γ=90.00°
C18H14N2O
C18H14N2O
Molecular Pharmaceutics (2007) 4, 3 401
a=9.906(12)Å b=21.65(3)Å c=7.590(9)Å
α=90.00° β=112.14(2)° γ=90.00°
C18H14N2O
C18H14N2O
Molecular Pharmaceutics (2007) 4, 3 401
a=26.217(13)Å b=7.481(5)Å c=19.410(10)Å
α=90.00° β=128.310(14)° γ=90.00°
C24H18N4O2
C24H18N4O2
Molecular Pharmaceutics (2007) 4, 3 401
a=12.7871(17)Å b=7.2838(9)Å c=44.445(6)Å
α=90.00° β=90.895(3)° γ=90.00°
C19H15N3O
C19H15N3O
Molecular Pharmaceutics (2007) 4, 3 401
a=18.503(3)Å b=7.5019(10)Å c=21.971(3)Å
α=90.00° β=92.181(4)° γ=90.00°
C19H15N3O
C19H15N3O
Molecular Pharmaceutics (2007) 4, 3 401
a=7.616(2)Å b=10.003(3)Å c=22.497(6)Å
α=87.342(5)° β=81.024(6)° γ=69.737(6)°
C26H22N4O2
C26H22N4O2
Molecular Pharmaceutics (2007) 4, 3 401
a=13.223(3)Å b=6.1971(12)Å c=14.630(3)Å
α=90.00° β=113.661(3)° γ=90.00°
C26H20N4O2
C26H20N4O2
Molecular Pharmaceutics (2007) 4, 3 401
a=16.5421(17)Å b=7.5056(8)Å c=18.709(2)Å
α=90.00° β=106.763(2)° γ=90.00°
C24H18N4O2
C24H18N4O2
Molecular Pharmaceutics (2007) 4, 3 401
a=20.866(6)Å b=7.437(2)Å c=6.7662(18)Å
α=90.00° β=98.142(5)° γ=90.00°
C24H18N4O2
C24H18N4O2
Molecular Pharmaceutics (2007) 4, 3 401
a=3.8483(17)Å b=8.755(4)Å c=14.364(6)Å
α=96.647(7)° β=94.498(8)° γ=95.474(7)°
C26H22N4O2
C26H22N4O2
Molecular Pharmaceutics (2007) 4, 3 401
a=11.195(3)Å b=7.335(2)Å c=13.530(4)Å
α=90.00° β=99.465(7)° γ=90.00°
C26H20N4O2
C26H20N4O2
Molecular Pharmaceutics (2007) 4, 3 401
a=14.660(3)Å b=4.1100(8)Å c=18.290(4)Å
α=90.00° β=90.74(3)° γ=90.00°
C24H18N6O3
C24H18N6O3
Molecular Pharmaceutics (2007) 4, 3 401
a=7.889(3)Å b=8.156(3)Å c=19.673(7)Å
α=83.866(7)° β=85.627(6)° γ=63.512(5)°
C24H18N4O2
C24H18N4O2
Molecular Pharmaceutics (2007) 4, 3 401
a=39.87(2)Å b=7.586(5)Å c=6.915(4)Å
α=90.00° β=91.972(19)° γ=90.00°
C18H14N4O2
C18H14N4O2
Molecular Pharmaceutics (2007) 4, 3 401
a=9.171(4)Å b=9.941(5)Å c=10.265(5)Å
α=95.674(8)° β=94.987(8)° γ=114.784(8)°
C30H24F4N4O4S
C30H24F4N4O4S
Molecular Pharmaceutics (2007) 4, 3 401
a=8.274(3)Å b=10.172(3)Å c=18.601(7)Å
α=87.521(7)° β=78.256(6)° γ=71.067(7)°